Russell Investments Group’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-5
Closed -$61K 2897
2018
Q1
$61K Buy
+5
New +$61K ﹤0.01% 2807